CO4761067A1 - Nuevas heteroalioxazolidinonas - Google Patents

Nuevas heteroalioxazolidinonas

Info

Publication number
CO4761067A1
CO4761067A1 CO97006152A CO97006152A CO4761067A1 CO 4761067 A1 CO4761067 A1 CO 4761067A1 CO 97006152 A CO97006152 A CO 97006152A CO 97006152 A CO97006152 A CO 97006152A CO 4761067 A1 CO4761067 A1 CO 4761067A1
Authority
CO
Colombia
Prior art keywords
straight
carbon atoms
substituted
different
same
Prior art date
Application number
CO97006152A
Other languages
English (en)
Spanish (es)
Inventor
Bernd Riedl
Dieter Habich
Andreas Stolle
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Amm Raomer Emder
Hein-Peter Kroll
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CO4761067A1 publication Critical patent/CO4761067A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CO97006152A 1996-02-06 1997-02-06 Nuevas heteroalioxazolidinonas CO4761067A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604224 1996-02-06
DE19649095A DE19649095A1 (de) 1996-02-06 1996-11-27 Neue Heteroaryl-Oxazolidinone

Publications (1)

Publication Number Publication Date
CO4761067A1 true CO4761067A1 (es) 1999-04-27

Family

ID=7784634

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97006152A CO4761067A1 (es) 1996-02-06 1997-02-06 Nuevas heteroalioxazolidinonas

Country Status (10)

Country Link
KR (1) KR970061891A (sh)
AR (1) AR005704A1 (sh)
CO (1) CO4761067A1 (sh)
DE (1) DE19649095A1 (sh)
PE (1) PE36098A1 (sh)
SV (1) SV1997000010A (sh)
TN (1) TNSN97033A1 (sh)
TW (1) TW362974B (sh)
YU (1) YU4497A (sh)
ZA (1) ZA97928B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
WO1999037630A1 (en) 1998-01-23 1999-07-29 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO2006106426A1 (en) * 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc An oxindole oxazolidinone as antibacterial agent
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
TW200815428A (en) 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators

Also Published As

Publication number Publication date
ZA97928B (en) 1997-08-05
SV1997000010A (es) 1997-10-23
KR970061891A (ko) 1997-09-12
AR005704A1 (es) 1999-07-14
PE36098A1 (es) 1998-08-29
TW362974B (en) 1999-07-01
DE19649095A1 (de) 1997-08-07
YU4497A (sh) 1999-09-27
TNSN97033A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
AR040346A2 (es) Compuestos intermediarios para la sintesis de benzamido-piperidinas
CO5021127A1 (es) Nuevas dihidropirimidas
AR035548A1 (es) Compuestos organicos
AR015765A1 (es) Dihidropirimidinas 2 heterociclicamente sustituidas, proceso para su preparacion, medicamentos que los contienen, proceso para la preparacion de los mismosuso de dichos dihidropirimidinas para la preparacion de un medicamento.
AR036111A1 (es) Compuesto de n-[alfa-aminoalcanoil]-3-fluorpirrolidina; composicion farmaceutica formulada con dicho compuesto; su uso en la preparacion de dicha composicion y metodo para el tratamiento de la diabetes tipo 2 utilizando dicho compuesto
ES2191484T3 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
CO4600675A1 (es) Derivados de oxalilamino-benzofurano y benzotienilo
CO5060482A1 (es) Derivados terapeuticos de biarilo
AR010331A1 (es) Compuestos derivados de 6-fenilpiridil-2-amina utiles como inhibidores nos, composiciones farmaceuticas que comprenden dichos compuestos, y metodosde tratamiento utilizando dichos compuestos.
PE20040373A1 (es) Composiciones herbicidas que comprenden derivados de isoxazolina
CO5640117A2 (es) Derivados de 2,4-diamonopirimidina
MX9405286A (es) Nuevos herbicidas.
ES2175919T3 (es) Derivados del camptothecin con actividad antitumoral.
ES2098117T3 (es) Anilinas como agente de marcaje para aceites minerales.
ES2188225T3 (es) Dihydro-(1,2,3)triazolo-(4,5-d)dippirimidin-7-ona-
AR010310A1 (es) Derivados de pirazol sustituidos, procedimiento para su preparacion, medicamentos que los comprenden, procedimiento para su produccion, uso de los mismos para la produccion de medicamentos.
CO4761067A1 (es) Nuevas heteroalioxazolidinonas
AR016131A1 (es) -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos.
AR012622A1 (es) Inhibidores de proteasas, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de los mismos en la fabricacion de unmedicamento
PE20001516A1 (es) Compuestos triciclicos como inhibidores de la farnesil transferasa
CO4650117A1 (es) Derivados de bencilsulfuro y proceso para su produccion .
CO4950561A1 (es) Derivados de ergolina
AR027744A1 (es) Compuestos de eter difenilico utiles en terapia
ES2064103T3 (es) Derivados de bifenil-guanidina sustituidos en posicion orto y agentes antidiabeticos o hipoglicemicos que los contienen.
AR016644A1 (es) Compuestos de 2-aminopiridinas con sustituyentes alcoxi ramificados, composicion farmaceutica y uso para la manufactura de medicamentos